# MCLE (Medicale Corp.) - SEC EDGAR Financial Statements

> Medicale Corp. reported $0 in total assets and a net loss of $30K through September 30, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MCLE
- Markdown: https://convexityos.com/fundamentals/MCLE.md
- SEC CIK: 0001827855
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001827855&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Sep 30, 2025 |
| Operating Income | FY 2025 | -$22K | Operating profit |
| Net Income | FY 2025 | -$30K | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 |
| Total Operating Expenses | $33K | $55K | $38K | $44K | $32K |
| **Operating Income** | -$33K | -$55K | -$38K | -$44K | -$32K |
| Interest Expense | $7.5K | $3.5K | $0 | -- | -- |
| Income Before Tax | -- | -$58K | -$38K | -$44K | -$32K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$41K | -$58K | -$37K | -$46K | -$32K |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| **Diluted EPS** | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Basic Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 3.6M |
| Diluted Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 3.6M |

### Income Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $3.1K | $8.7K | $3.6K | $6.3K | $15K | $16K | $9.3K | $11K |
| **Operating Income** | -$3.1K | -$8.7K | -$3.6K | -$6.3K | -$15K | -$16K | -$9.3K | -$11K |
| Interest Expense | $2.1K | $2.0K | $2.0K | $1.8K | $1.7K | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -- | -$17K | -$10K | -$12K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$5.3K | -$11K | -$5.5K | -$8.3K | -$17K | -$17K | -$10K | -$12K |
| Basic EPS | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| Basic Shares Outstanding | 5.9M | -- | 5.9M | 5.9M | 5.9M | -- | 5.9M | 5.9M |
| Diluted Shares Outstanding | 5.9M | -- | 5.9M | 5.9M | 5.9M | -- | 5.9M | 5.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $159 | $159 | $0 | $18K | $0 |
| **Cash & Short-Term Investments** | $0 | $159 | $159 | $0 | $18K | $0 |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $0 |
| **Total Current Assets** | $0 | $159 | $159 | $0 | $19K | $200 |
| Intangible Assets | -- | -- | $0 | $0 | $9.6K | $12K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $9.6K | $12K |
| **Total Assets** | $0 | $159 | $159 | $0 | $28K | $12K |
| Accounts Payable | -- | $0 | -- | -- | -- | $12K |
| Short-Term Debt | -- | -- | -- | -- | -- | $1.0K |
| **Total Current Liabilities** | $34K | $16K | $41K | $55K | $37K | $14K |
| **Total Non-Current Liabilities** | $106K | $84K | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $140K | $99K | $41K | $55K | $37K | $14K |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $1.0K |
| Common Stock | $592 | $592 | $592 | $592 | $592 | $340 |
| Retained Earnings | -$217K | -$176K | -$118K | -$80K | -$34K | -$1.9K |
| **Total Stockholders' Equity** | -$140K | -$99K | -$41K | -$55K | -$8.4K | -$1.4K |
| Total Equity | -$140K | -$99K | -$41K | -$55K | -$8.4K | -$1.4K |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $0 | -- | -- | $159 | $159 | $159 | $159 |
| **Cash & Short-Term Investments** | -- | $0 | -- | -- | $159 | $159 | $159 | $159 |
| **Total Current Assets** | $0 | $0 | $0 | $0 | $159 | $159 | $159 | $159 |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $0 | $0 | $0 | $0 | $159 | $159 | $159 | $159 |
| Accounts Payable | -- | -- | -- | -- | $995 | $0 | -- | -- |
| **Total Current Liabilities** | $32K | $34K | $29K | $26K | $18K | $16K | $14K | $13K |
| **Total Non-Current Liabilities** | $113K | $106K | $100K | $98K | $94K | $84K | $68K | $59K |
| **Total Liabilities** | $145K | $140K | $129K | $124K | $112K | $99K | $82K | $72K |
| Common Stock | $592 | $592 | $592 | $592 | $592 | $592 | $592 | $592 |
| Retained Earnings | -$222K | -$217K | -$206K | -$201K | -$189K | -$176K | -$159K | -$149K |
| **Total Stockholders' Equity** | -$145K | -$140K | -$129K | -$124K | -$116K | -$99K | -$82K | -$72K |
| Total Equity | -$145K | -$140K | -$129K | -$124K | -$116K | -$99K | -$82K | -$72K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$41K | -$58K | -$37K | -$46K | -$32K |
| Change in Payables | $11K | -$4.9K | -- | -- | -- |
| **Operating Cash Flow** | -$23K | -$84K | -$26K | -$25K | -$18K |
| **Investing Cash Flow** | -- | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $25K |
| **Financing Cash Flow** | $23K | $84K | $26K | $6.1K | $36K |
| **Net Change in Cash** | -$159 | $0 | $159 | -$18K | $18K |

### Cash Flow Statement (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.3K | -$11K | -$5.5K | -$8.3K | -$17K | -$17K | -$10K | -$12K |
| Change in Payables | -$3.6K | $2.2K | $1.6K | $1.9K | $5.0K | $1.4K | $1.2K | $962 |
| **Operating Cash Flow** | -$6.7K | -$6.5K | -$2.0K | -$4.5K | -$10K | -$16K | -$9.3K | -$31K |
| **Financing Cash Flow** | $6.7K | $6.5K | $2.0K | $4.4K | $10K | $16K | $9.3K | $31K |
| **Net Change in Cash** | $0 | $0 | $0 | -$159 | $0 | $0 | $0 | $0 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -- | -36611.9% | -23357.2% | -- | -113.7% |
| Current Ratio | 0.00x | 0.01x | 0.00x | 0.00x | 0.51x |
| Quick Ratio | 0.00x | 0.01x | 0.00x | 0.00x | 0.50x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -- | -- | -- | -- | -34959.7% | -36611.9% | -34942.8% | -33732.7% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| Quick Ratio | -- | 0.00x | -- | -- | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
